Toggle: English / Spanish
Graves disease is an
that leads to overactivity of the thyroid gland (). An is a condition that occurs when the immune system mistakenly attacks healthy tissue.
Diffuse thyrotoxic goiter
The thyroid gland is an important organ of the
system. The gland is located at the front of the neck above where the collarbones meet. This gland releases the hormones (T4) and (T3), which control body . Controlling metabolism is important for regulating mood, weight, and mental and physical energy levels.
When the body makes too much thyroid hormone, the condition is called hyperthyroidism. (An underactive thyroid leads to hypothyroidism.)
Graves disease is the most common cause of hyperthyroidism. It is due to an abnormal immune system response that causes the thyroid gland to produce too much thyroid hormone. Graves disease is most common in women over age 20. But the disorder can occur at any age and can affect men as well.
Younger patients may have these symptoms:
- Breast enlargement in men (possible)
- Difficulty concentrating
- Double vision
- Eyeballs that bulge (exophthalmos)
- Eye irritation and tearing
- Frequent bowel movements
- Goiter (possible)
- Heat intolerance
- Increased appetite
- Increased sweating
- Irregular menstrual periods in women
- Muscle weakness of the hips and shoulders
- Rapid or irregular heartbeat (palpitations or arrhythmia)
- Restlessness and difficulty sleeping
- Shortness of breath with activity
- Weight loss (weight gain in some cases)
Older patients may have these symptoms:
Exams and Tests
The health care provider will do a physical exam and may find that you have an increased heart rate. An exam of your neck may find that your thyroid gland is enlarged (goiter).
Other tests include:
This disease may also affect the following test results:
- Orbit CT scan or ultrasound
- Thyroid stimulating immunoglobulin (TSI)
- Thyroid peroxidase (TPO) antibody
- Anti-TSH receptor antibody
Treatment is aimed at controlling your overactive thyroid. Medicines called beta-blockers are often used to treat symptoms of rapid heart rate, sweating, and anxiety until the hyperthyroidism is controlled. Hyperthyroidism is treated with one or more of the following:
- Antithyroid medications
- Radioactive iodine
If you have had radioactive iodine treatment or surgery, you will need to take replacement thyroid hormones for the rest of your life. This is because these treatments destroy or remove the gland.
Some of the eye problems related to Graves disease usually improve when hyperthyroidism is treated with medications, radiation, or surgery. Radioactive iodine can sometimes make eye problems worse. Eye problems are worse in people who smoke, even after the hyperthyroidism is treated.
Sometimes prednisone (a steroid medication that suppresses the immune system) is needed to reduce eye irritation and swelling.
You may need to tape your eyes closed at night to prevent drying. Sunglasses and eye drops may reduce eye irritation. In rare cases, surgery or radiation therapy (different from radioactive iodine) may be needed to prevent further damage to the eye and loss of vision.
Graves disease often responds well to treatment. Treatments such as radioactive iodine treatment or surgery destroy or remove the thyroid gland. If you have these treatments, you will have an underactive thyroid (hypothyroidism). You will need to take replacement thyroid hormones for the rest of your life.
If you do not get the correct dosage of thyroid hormone replacement, hypothyroidism can lead to:
- Mental and physical sluggishness
- Weight gain
When to Contact a Medical Professional
Call your health care provider if you have symptoms of Graves disease. Also call if your eye problems or other symptoms get worse or do not improve with treatment.
Go to the emergency room or call the local emergency number (such as 911) if you have symptoms of hyperthyroidism with:
- Decrease in consciousness
- Rapid, irregular heartbeat
Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17(3):456-520. PMID: 21700562 www.ncbi.nlm.nih.gov/pubmed/21700562.
Cockerman KP, Chan SS. Thyroid eye disease. Neurol Clin. 2010;28:729-55. PMID: 20637998 www.ncbi.nlm.nih.gov/pubmed/20637998.
Mandel SJ, Larsen PR, Davies TF. Thyrotoxicosis. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 12th ed. Philadelphia, PA: Elsevier Saunders; 2011:chap 12.
- Last reviewed on 5/10/2014
- Brent Wisse, MD, Associate Professor of Medicine, Division of Metabolism, Endocrinology & Nutrition, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2013 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.